Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus <i>Plagiochila</i>

The present analysis retraces the discovery of plagiochilins A-to-W, a series of seco-aromadendrane-type sesquiterpenes isolated from diverse leafy liverworts of the genus <i>Plagiochila</i>. Between 1978, with the first isolation of the leader product plagiochilin A from <i>P. yok...

Full description

Bibliographic Details
Main Author: Christian Bailly
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/3/758
_version_ 1797610574992900096
author Christian Bailly
author_facet Christian Bailly
author_sort Christian Bailly
collection DOAJ
description The present analysis retraces the discovery of plagiochilins A-to-W, a series of seco-aromadendrane-type sesquiterpenes isolated from diverse leafy liverworts of the genus <i>Plagiochila</i>. Between 1978, with the first isolation of the leader product plagiochilin A from <i>P. yokogurensis</i>, and 2005, with the characterization of plagiochilin X from <i>P. asplenioides</i>, a set of 24 plagiochilins and several derivatives (plagiochilide, plagiochilal A-B) has been isolated and characterized. Analogue compounds recently described are also evoked, such as the plagiochianins and plagicosins. All these compounds have been little studied from a pharmacological viewpoint. However, plagiochilins A and C have revealed marked antiproliferative activities against cultured cancer cells. Plagiochilin A functions as an inhibitor of the termination phase of cytokinesis: the membrane abscission stage. This unique, innovative mechanism of action, coupled with its marked anticancer action, notably against prostate cancer cells, make plagiochilin A an interesting lead molecule for the development of novel anticancer agents. There are known options to increase its potency, as deduced from structure–activity relationships. The analysis shed light on this family of bryophyte species and the little-known group of bioactive terpenoid plagiochilins. Plagiochilin A and derivatives shall be further exploited for the design of novel anticancer targeting the cytokinesis pathway.
first_indexed 2024-03-11T06:17:08Z
format Article
id doaj.art-4ca9eaafefcf4dfbaa8494e51927e55c
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-11T06:17:08Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-4ca9eaafefcf4dfbaa8494e51927e55c2023-11-17T12:11:58ZengMDPI AGLife2075-17292023-03-0113375810.3390/life13030758Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus <i>Plagiochila</i>Christian Bailly0Institut de Chimie Pharmaceutique Albert Lespagnol (ICPAL), Faculté de Pharmacie, University of Lille, 3 rue du Professeur Laguesse, F-59006 Lille, FranceThe present analysis retraces the discovery of plagiochilins A-to-W, a series of seco-aromadendrane-type sesquiterpenes isolated from diverse leafy liverworts of the genus <i>Plagiochila</i>. Between 1978, with the first isolation of the leader product plagiochilin A from <i>P. yokogurensis</i>, and 2005, with the characterization of plagiochilin X from <i>P. asplenioides</i>, a set of 24 plagiochilins and several derivatives (plagiochilide, plagiochilal A-B) has been isolated and characterized. Analogue compounds recently described are also evoked, such as the plagiochianins and plagicosins. All these compounds have been little studied from a pharmacological viewpoint. However, plagiochilins A and C have revealed marked antiproliferative activities against cultured cancer cells. Plagiochilin A functions as an inhibitor of the termination phase of cytokinesis: the membrane abscission stage. This unique, innovative mechanism of action, coupled with its marked anticancer action, notably against prostate cancer cells, make plagiochilin A an interesting lead molecule for the development of novel anticancer agents. There are known options to increase its potency, as deduced from structure–activity relationships. The analysis shed light on this family of bryophyte species and the little-known group of bioactive terpenoid plagiochilins. Plagiochilin A and derivatives shall be further exploited for the design of novel anticancer targeting the cytokinesis pathway.https://www.mdpi.com/2075-1729/13/3/758anticancer agentsaromadendranebryophytescytokinesis inhibitor<i>Plagiochila</i> speciesplagiochilins
spellingShingle Christian Bailly
Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus <i>Plagiochila</i>
Life
anticancer agents
aromadendrane
bryophytes
cytokinesis inhibitor
<i>Plagiochila</i> species
plagiochilins
title Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus <i>Plagiochila</i>
title_full Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus <i>Plagiochila</i>
title_fullStr Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus <i>Plagiochila</i>
title_full_unstemmed Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus <i>Plagiochila</i>
title_short Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus <i>Plagiochila</i>
title_sort discovery and anticancer activity of the plagiochilins from the liverwort genus i plagiochila i
topic anticancer agents
aromadendrane
bryophytes
cytokinesis inhibitor
<i>Plagiochila</i> species
plagiochilins
url https://www.mdpi.com/2075-1729/13/3/758
work_keys_str_mv AT christianbailly discoveryandanticanceractivityoftheplagiochilinsfromtheliverwortgenusiplagiochilai